multi system organ failure which led to his death. The important features in each system are described in turn. The day of ingestion is taken as Day 1.
Cardiovascular. The patient's pulse, blood pressure and CVP remained within normal limits until Day 3 when his arterial pressure and CVP began to fall rapidly. He was given freezedried plasma and dopamine by infusion. Swan-Ganz (SG) catheterisation was considered, but was deferred because of clinical bleeding and the grossly abnormal coagulation tests which had persisted in spite of treatment with vitamin K and freeze-dried plasma. On Day 4 he had two episodes of bradycardia followed by asystole from which he was resuscitated. On Day 5, ischemic changes were first seen on his electrocardiogram. Later that day, he had a further cardiac arrest, again with successful resuscitation, but after this episode an adrenaline infusion as well as the dopamine was required to maintain the cardiac output. He had one further cardiac arrest from which he could not be resuscitated. Respiratory. The patient was initially tachypnoeic but not hypoxic. Early on Day 3 he became hypoxic on air, and supplementary oxygen was given by mask. Later that day worsening ventilatory failure made intubation and controlled ventilation necessary. Subsequently increasing inspired oxygen concentrations and PEEP levels were required to achieve P a o 2 levels within the normal range ( Figure 1 ). In the final 24 hours Pa02 levels between 7.5 and 10 kPa had to be tolerated.
Serial chest X-ray examinations showed changes consistent with Adult Respiratory Distress Syndrome (ARDS). Metabolic abnormalities. Initial arterial blood gases showed a pH 7.345 and a base excess of -9.0 mmo1. The arterial lactate was 4.5 mmolll (normal 0.3-0.8 mmol). Despite repeated corrections with intravenous sodium bicarbonate, the lactic acidosis continued and worsened, finally reaching 17.9 mmolll on Day 5 ( Figure 1 ).
Elevated alkaline phosphatase and aspartate transaminase levels suggested hepatocellular damage. Hypocalcemia, hypokalemia, and hypophosphatemia required vigorous replacement.
Bone marrow suppression. On Day 3 signs of bone marrow supression were seen. The WBC count of 39 x 10 9 11 found on admission had fallen to 1.9 x 10 9 /1, a level from which it never recovered. His haemoglobin level had fallen in corresponding time from 162 to 72 gll and his platelet count from 361 to 49 x 10 9 /1. These changes would have been caused in part by blood loss. He was given re suspended red cells and platelet concentrate.
Coagulopathy. The PR, APPT and FOPs were elevated at admission and remained so in spite of adequate treatment with vitamin K and :~~o~-
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freeze-dried plasma (Figure 2 ). He experienced obvious bleeding from the site of the arterial puncture, and from the nose and mouth as a result of the nasotracheal intubation. Fever. The patient became febrile on Day 2, the fever peaking at 40 DC. Antibiotics were begun, but despite careful searching, no infective cause was identified.
Renal. Initial anuria was corrected with fluid loading and inotropic support. Despite these measures and later, diuretic therapy, acute oliguric renal failure developed over the next two days with the serum creatinine rising to 0.43 mmoll1. His cardiovascular state and coagulopathy precluded dialysis.
The patient died on Day 5. A post mortem examination showed bloodstained frothy fluid in the trachea and major bronchi together with severe intra-alveolar haemorrhage. There was extensive confluent haemorrhage behind the pharynx and larynx, in the retroperitoneal tissues around both kidneys and in the pelvis. The grey matter was swollen and showed extensive patchy pallor suggestive of multiple foci of ischemia. Microscopic examination showed changes of cerebral oedema with probable intravascular coagulation and haemolysis. 
DISCUSSION
Colchicine is a lipid-soluble alkaloid of the autumn crocus, Colchicum autumnale. It is rapidly absorbed from the intestinal tract, is about 50070 bound to plasma protein 4 and has a large volume of distribution, 2.2 lIkg. This feature limits the use of haemodialysis in the management of colchicine poisoning. 5 The signs and symptoms of colchicine intoxication have recently been reviewed by Stapczynski et al. ) Our patient's condition closely followed the time course they noted, and it showed all the common features that have been described (Table 1) . He also showed evidence of ARDS which Hill et al. have reported. 6 In a European series,7 patients who took less than 0.5 mg/kg usually survived, whereas those taking more than 0.8 mg/kg died. This patient took approximately 0.4 mg/kg, and although survival after colchicine poisoning with multisystem failure has been reported,8,9 the delay of 24 hours before presentation pn'cluded emergency treatment and may have contrilJuted to his death.
Failure to introduce a pulmonary artery catheter before the coagulopathy developed added to the difficulties of management. Colchicine is a very useful drug in the management of acute gouty arthritis and some authors 10 advocate doses up to 6 mg in acute gout. This is close to the minimum reported fatal dose of 7 mg, but toxicity should not occur if the loading dose is followed by a small dose every two hours until gastrointestinal sideeffects occur.
Quinine and quinidine are optical isomers, but quinidine is the more toxic. Our laboratory measures both isomers equally, and the level was never above the therapeutic range for quinidine. We therefore concluded that the quinine played no part in the patient's illness.
This case illustrates the severe widespread toxic and potentially lethal effects of colchicine and the extreme risks in its overdose.
